Electronic nudges had a small impact on flu vaccine uptake in patients without diabetes but showed no significant effect among diabetic patients, suggesting the need for tailored strategies for this group.
Avalon’s latest biotech closes $58M round as it pursues treatments for autoimmune brain conditions
Arialys Therapeutics announced Tuesday that it tied the bow on a $58 million seed round to develop treatments specifically for brain disorders caused by immune